Nanoparticles skin absorption: New aspects for a safety profile evaluation

Regulatory Toxicology and Pharmacology

Volumn 72, Issue 2, 2015, Pages 310-322

  Larese Filon, Francesca ^a   Mauro, Marcella ^a   Adami, Gianpiero ^a   Bovenzi, Massimo ^a   Crosera, Matteo ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Nanoparticles interaction in physiological media; Nanoparticles size; Nanoparticles skin absorption; Review; Shape; Surface properties

Indexed keywords

CARBON NANOTUBE; FULLERENE DERIVATIVE; GOLD NANOPARTICLE; METAL OXIDE; NANOPARTICLE; POLYSTYRENE NANOPARTICLE; QUANTUM DOT; SILICA NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE;

DECISION TREE; DISSOLUTION; ENVIRONMENTAL EXPOSURE; HUMAN; HYDRODYNAMICS; MOLECULAR INTERACTION; NANOTOXICOLOGY; NONHUMAN; NOTE; PARTICLE SIZE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; SENSITIZATION; SKIN ABSORPTION; SKIN DEFECT; SKIN IRRITATION; SKIN PENETRATION; SKIN PERMEABILITY; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL; ANIMAL; DRUG EFFECTS; METABOLISM; SKIN;

ANIMALS; HUMANS; NANOPARTICLES; RISK ASSESSMENT; SKIN; SKIN ABSORPTION;

EID: 84929403165     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.05.005     Document Type: Note

References (128)

1. Adachi K., Yamada N., Yoshida Y., Yamamoto O. Subchronic exposure of titanium dioxide nanoparticles to hairless rat skin. Exp. Dermatol. 2013, 22(4):278-283.
2. Altunbek M., Baysal A., Çulha M. Influence of surface properties of zinc oxide nanoparticles on their cytotoxicity. Colloids Surf B Biointerfaces 2014, 1(121):106-113. 10.1016/j.colsurfb.2014.05.034.
3. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 2004, 99(1):53-62.
4. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., López-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J. Invest. Dermatol. 2007, 127(7):1701-1712.
5. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., Lopez-Quintela A. Penetration of metallic nanoparticles in human full-thickness skin. J. Invest. Dermatol. 2007, 127:1701-1712.
6. Bennat C., Müller-Goymann C.C. Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int. J. Cosmet. Sci. 2000, 22(4):271-283.
7. Bennett S.W., Zhou D., Mielke R., Keller A.A. Photoinduced disaggregation of TiO2 nanoparticles enables transdermal penetration. PLoS One 2012, 7(11):e48719. 10.1371/journal.pone.0048719.
8. Bianco C., Adami G., Crosera M., Larese F., Casarin S., Castagnoli C., Stella M., Maina G. Silver percutaneous absorption after exposure to silver nanoparticles: a comparison study of three human skin graft samples used for clinical applications. Burns 2014, 40(7):1390-1396.
9. Blume-Peytavi U., Massoudy L., Patzelt A., Lademann J., Dietz E., Rasulev U., Garcia Bartels N. Follicular and percutaneous penetration pathways of topically applied minoxidil foam. Eur. J. Pharm. Biopharm. 2010, 76(3):450-453.
10. Campbell C.S., Contreras-Rojas L.R., Delgado-Charro M.B., Guy R.H. Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. J. Control. Release 2012, 162(1):201-207.
11. Chu M., Wu Q., Wang J., Hou S., Miao Y., Peng J., et al. In vitro and in vivo transdermal delivery capacity of quantum dots through mouse skin. Nanotechnology 2007, 18:455103. 10.1088/0957-4484/18/45/455103.
12. Crosera M., Bovenzi M., Maina G., Adami G., Zanette C., Florio C., Filon Larese F. Nanoparticle dermal absorption and toxicity: a review of the literature. Int. Arch. Occup. Environ. Health 2009, 82(9):1043-1055.
13. Cross S.E., Innes B., Roberts M., Tsuzuki T., Robertson T.A., McCormick P. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol. Physiol. 2007, 20:148-154.
14. Degim I.T., Burgess D.J., Papadimitrakopoulos F. Carbon nanotubes for transdermal drug delivery. J. Microencapsul. 2010, 27(8):669-681.
15. Detoni C.B., Coradini K., Back P., Oliveira C.M., Andrade D.F., Beck R.C., Pohlmann A.R., Guterres S.S. Penetration, photo-reactivity and photoprotective properties of nanosized ZnO. Photochem. Photobiol. Sci. 2014, 13(9):1253-1260. 10.1039/c3 pp50373a.
16. Dickel H.I., Kuss O., Schmidt A., Kretz J., Diepgen T.L. Importance of irritant contact dermatitis in occupational skin disease. Am. J. Clin. Dermatol. 2002, 3(4):283-289.
17. Durand L., Habran N., Henschel V., Amighi K. In vitro evaluation of the cutaneous penetration of sprayable sunscreen emulsions with high concentrations of UV filters. Int. J. Cosmet. Sci. 2009, 31(4):279-292.
18. Eedy D.J. Carbon fibre induced airborne irritant contact dermatitis. Contact Dermatitis 1996, 35:362-363.
19. Elias P.M. Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol. 1983, 80(Suppl.):44S-49S.
20. Elsner P. Irritant dermatitis in the workplace. Dermatol. Clin. 1994, 12:461-467.
21. Ema M., Matsuda A., Kobayashi N., Naya M., Nakanishi J. Dermal and ocular irritation and skin sensitization studies of fullerene C60 nanoparticles. Cutan. Ocul. Toxicol. 2013, 32(2):128-134.
22. Faunce T., Murray K., Nasu H., Bowman D. Sunscreen safety: the precautionary principle; the Australian Therapeutic Goods Administration and nanoparticles in sunscreens. Nanoethics 2008, 2:231-240.
23. Filipe P., Silva J.N., Silva R., Cirne de Castro J.L., Marques Gomes M., Alves L.C., Santus R., Pinheiro T. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol. Physiol. 2009, 22(5):266-275.
24. Filon F.L., D'Agostin F., Crosera M., Adami G., Rosani R., Romano C., Bovenzi M., Maina G. In vitro percutaneous absorption of silver nanoparticles. G. Ital. Med. Lav. Ergon. 2007, 29(3 Suppl.):451-452.
25. Fluhr J.W., Dickel H., Kuss O., Weyher I., Diepgen T.L., Berardesca E.I. Impact of anatomical location on barrier recovery; surface pH and stratum corneum hydration after acute barrier disruption. Br. J. Dermatol. 2002, 146:770-776.
26. Franz T.J. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64(3):190-195.
27. Gamer A.D., Leibolt E., van Ravenzwaay B. The in-vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol. In Vitro 2006, 20:301-307.
28. George R., Merten S., Wang T.T., Kennedy P., Maitz P. In vivo analysis of dermal and systemic absorption of silver nanoparticles through healthy human skin. Australas. J. Dermatol. 2014, 55(3):185-190. Epub 2013 Sep 5. 10.1111/ajd.12101.
29. Goldstein A., Soroka Y., Frušić-Zlotkin M., Popov I., Kohen R. High resolution SEM imaging of gold nanoparticles in cells and tissues. J. Microsc. 2014, 256(3):237-247. Epub 2014 Sep 16. 10.1111/jmi.12179.
30. Gontier E., Ynsa M.D., Bíró T., Hunyadi J., Kiss B., Gáspár K., Pinheiro T., Silva J.N., Filipe P., Stachura J., Dabros W., Reinert T., Butz T., Moretto P., Surlève-Bazeille J.E. Is there penetration of titania nanoparticles in sunscreens through skin? A comparative electron and ion microscopy study. Nanotoxicology 2008, 2(4):218-231.
31. Gopee N.V., Roberts D.W., Webb P., Cozart C.R., Siitonen P.H., Latendresse J.R., Warbitton A.R., Yu W.W., Colvin V.L., Walker N.J., Howard P.C. Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. Toxicol. Sci. 2009, 111(1):37-48.
32. Graf C., Meinke M., Gao Q., Hadam S., Raabe J., Sterry W., Blume-Peytavi U., Lademann J., Rühl E., Vogt A. Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission X-ray microscopy. J. Biomed. Opt. 2009, 14(2):021015.
33. Gratieri T., Schaeter U.F., Jing L., Gao M., Lopez R.F.V., Schneider M. Penetration of quantum dot particles through human skin. J. Biomed. Nanotechnol. 2010, 6:586-595.
34. Gulson B., McCall M., Korsch M., Gomez L., Casey P., Oytam Y., Taylor A., McCulloch M., Trotter J., Kinsley L., Greenoak G. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol. Sci. 2010, 118(1):140-149.
35. Gulson B., Wong H., Korsch M., Gomez L., Casey P., McCall M., McCulloch M., Trotter J., Stauber J., Greenoak G. Comparison of dermal absorption of zinc from different sunscreen formulations and differing UV exposure based on stable isotope tracing. Sci. Total Environ. 2012, 420:313-318.
36. Hirai T., Yoshikawa T., Nabeshi H., Yoshida T., Akase T., Yoshioka Y., Itoh N., Tsutsumi Y. Dermal absorption of amorphous nanosilica particles after topical exposure for three days. Pharmazie 2012, 67(8):742-743.
37. Holbrook K.A., Odland G.F. Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis. J. Invest. Dermatol. 1974, 62(4):415-422.
38. Hsieh S.F., Bello D., Schmidt D.F., Pal A.K., Rogers E.J. Biological oxidative damage by carbon nanotubes: fingerprint or footprint?. Nanotoxicology 2012, 6(1):61-76.
39. Huang Y., Yu F., Park Y.S., Wanh J., Shin M.C., Chung H.S., Yang V.C. Coadministration of protein drugs with gold nanoparticles to enable percutaneous delivery. Biomaterials 2010, 31(34):9086-9091.
40. Jeong S.H., Kim J.H., Hi S.M., Lee J.P., Sohn K.H. Assessment of penetration of quantum dots through in vitro and in vivo human skin using the human skin equivalent model and the tape stripping method. Biochem. Biophys. Research. Commun. 2010, 394:612-615.
41. Jonaitis T.S., Card J.W., Magnuson B. Concerns regarding nano-sized titanium dioxide dermal penetration and toxicity study. Toxicol. Lett. 2010, 192(2):268-269.
42. Journeay W.S., Goldman R.H. Occupational handling of nickel nanoparticles: a case report. Am. J. Ind. Med. 2014, 57(9):1073-1076.
43. Journeay W.S., Goldman R.H. Occupational handling of nickel nanoparticles: a case report. Am. J. Ind. Med. 2014, 10.1002/agim.22344.
44. Kato S., Aoshima H., Saitoh Y., Miwa N. Biological safety of LipoFullerene composed of squalane and fullerene-C60 upon mutagenesis; photocytotoxicity; and permeability into the human skin tissue. Basic Clin. Pharmacol. Toxicol. 2009, 104(6):483-487.
45. Kertész Z., Szikszai Z., Gontier E., Moretto P., Surlève-Bazeillec G.E., Kissd B., Juhászd I., Hunyadid J., Kissa Á.Z. Nuclear microprobe study of TiO2-penetration in the epidermis of human skin xenografts. Nucl. Instr. Meth. Phys. Res., Sect. B 2005, 231(1-4):280-285.
46. Kim B., Han G., Toley B.J., Kim C.K., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 2010, 5(6):465-472.
47. Kishore A.S., Surekha P., Murthy P.B. Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicol. Lett. 2009, 191:268-274.
48. Kiss B., Bíró T., Czifra G., Tóth B.I., Kertész Z., Szikszai Z., Kiss A.Z., Juhász I., Zouboulis C.C., Hunyadi J. Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Exp. Dermatol. 2008, 17(8):659-667.
49. Knorr F., Lademann J., Patzelt A., Sterry W., Blume-Peytavi U., Vogt A. Follicular transport route - research progress and future perspectives. Eur. J. Pharm. Biopharm. 2009, 71:173-180.
50. Krishnan G., Edwards J., Chen Y., Benson H.A. Enhanced skin permeation of naltrexone by pulsed electromagnetic fields in human skin in vitro. J. Pharm. Sci. 2010, 99(6):2724-2731.
51. Kubo A., Nagao K., Armagal M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 2012, 122:440-447.
52. Kuo T.R., Wu C.L., Hsu C.T., Lo W., Chiang S.J., Lin S.J., et al. Chemical enhancer induced changes in mechanism of transdermal delivery of zinc oxide nanoparticles. Biomaterials 2009, 30:3002-3008.
53. Labala S., Mandapalli P.K., Kurumaddali A., Venuganti V.V. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma. Mol. Pharm. 2015, 12(3):878-888. Epub 2015 Jan 27. 10.1021/mp5007163.
54. Labouta H.I., Schneider M. Interaction of inorganic nanoparticles with the skin barrier: current status and critical review. Nanomedicine 2013, 9(1):39-54.
55. Lademann J., Weigmann H., Rickmeyer C., Barthelmes H., Schaefer H., Mueller G., Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin. Pharmacol. Appl. Skin Physiol. 1999, 12(5):247-256.
56. Lademann J., Otberg N., Richter H., Weigmann H.J., Lindemann U., Schaefer H., Sterry W. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol. 2001, 14(Suppl. 1):17-22.
57. Lademann J., Patzelt A., Richter H., Antoniou C., Sterry W., Knorr F. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J. Biomed. Opt. 2009, 14(2):021014.
58. Lane M.E. Nanoparticles and the skin-applications and limitations. J. Microencapsul. 2011, 28(8):709-716.
59. Larese, F., Crosera, M., Mauro, M., Bianco, C., Adami, G., Bovenzi, M., 2014. Human skin penetration of cobalt oxide nanoparticles through intact and damaged skin. In: Nanotox - International Nanotoxicology Congress, 23th-26th April 2014, Antalya, Turkey, p. 103.
60. Larese Filon F., Crosera M., Timeus E., Adami G., Bovenzi M., Ponti J., Maina G. Human skin penetration of cobalt nanoparticles through intact and damaged skin. Toxicol. In Vitro 2013, 27(1):121-127.
61. Larese Filon F., D'Agostin F., Bovenzi M., Crosera M., Adami G., Romano C., Maina G. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009, 255:33-37.
62. Larese Filon F., Crosera M., Adami G., Bovenzi M., Rossi F., Maina G. Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology 2011, 2010. (Early online 1-9). 10.3109/1743390..551428.
63. Larese Filon, F., Mauro, M., Crosera, M., Bovenzi, M., 2013. Poster: "Platinum and Rhodium nanoparticles skin absorption" Thematic workshop on Toxicology related topics eco-nano-. University of Nova Gorica, 13th-14th June 2013.
64. Larese Filon, F., Crosera, M., Adami, G., Comiati, Bovenzi M, Maina, G., 2014. Skin absorption of palladium nanoparticles: a new possible risk in the nanotechnology industry. In: 6th International Conference on Occupational and Environmental Skin to Chemicals, 2nd-3rd June 2014, Amsterdam, p. 88.
65. Lee S.E., Choi K.J., Menon G.K., Kim H.J., Choi E.H., Ahn S.K., Lee S.H. Penetration pathways induced by low-frequency sonophoresis with physical and chemical enhancers: iron oxide nanoparticles versus lanthanum nitrates. J. Invest. Dermatol 2010, 130:1063-1072.
66. Lee O., Jeong S.H., Shin W.U., Lee G., Oh C., Son S.W. Influence of surface charge of gold nanorods on skin penetration. Skin Res. Technol. 2013, 19(1):e390-e396.
67. Lekki J., Stachura Z., Dabroś W., Stachura J., Menzel F., Reinert T., Butz T., Pallon J., Gontier E., Ynsa M.D., et al. On the follicular pathway of percutaneous uptake of nanoparticles: ion microscopy and autoradiography studies. Nucl. Instr. Meth. Phys. Res. B. 2007, 260:174-177.
68. Leroueil P.R., Hong S., Mecke A., Baker J.R., Orr B.G., Banaszak Holl M.M. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?. Acc. Chem. Res. 2007, 40(5):335-342.
69. Mahe B., Vogt A., Liard C., Duffy D., Abadie V., Bonduelle O., Boissonnas A., Sterry W., Verrier B., Blume-Peytavi U., Combadiere B. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J. Invest. Dermatol. 2009, 129(5):1156-1164.
70. Mavon A., Miquel C., Lejeune O., Payre B., Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and mineral sunscreen. Skin Pharmacol. Physiol. 2007, 20:10-20.
71. Meding B. Differences between the sexes with regard to work-related skin diseases. Contact Dermatitis 2000, 43:65-71.
72. Menzel F., Reinert T., Vogt J., Butz T. Investigations of percutaneous uptake of ultrafine TiO2 particles at the high energy ion nanoprobe LIPSION. Nucl. Instr. Meth. Phys. Res., Sect. B 2004, 219-220:82-86.
73. Michaels A.S., Chandrasekaran S.K., Shaw J.E. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J. 1975, 21:985-996.
74. Miquel-Jeanjean C., Crépel F., Raufast V., Payre B., Datas L., Bessou-Touya S., Duplan H. Penetration study of formulated nanosized titanium dioxide in models of damaged and sun-irradiated skins. Photochem. Photobiol. 2012, 88(6):1513-1521.
75. Monteiro-Riviere N.A. Structure and function of skin. Informa Healthcare 2010, vol. 29:1-18. New York, NY, (Chapter 1). N.A. Monteiro-Riviere (Ed.).
76. Monteiro-Riviere N.A., Wiench K., Landsiedel R., Schulte S., Inman A.O., Riviere J.E. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Toxicol. Sci. 2011, 123(1):264-280.
77. Monteiro-Riviere N.A., Larese Filon F. Effects of engineered nanomaterials on skin. Adverse Effects of Engineered Nanomaterials 2012, 185-207. Elsevier, NY, (Chapter 11). B. Fadeel, A. Pietroiusti, A. Shvedova (Eds.).
78. Mortensen L.J., Oberdörster G., Pentland A.P., Delouise L.A. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett. 2008, 8(9):2779-2787.
79. Mortensen L., Zheng H., Faulknor R., De Benedetto A., Beek L., DeLouise L.A. Increased in vivo skin penetration of quantum dots with UVR and in vitro quantum dots cytotoxicity. Proc. SPIE Colloidal Quantum Dots Biomed. Appl IV 2009, 718919-12. 10.1117/12.809215.
80. Mortensen L.J., Jatana S., Gelein R., De Benedetto A., De Mesy Bentley K.L., Beck L.A., Elder A., Delouise L.A. Quantification of quantum dot murine skin penetration with UVR barrier impairment. Nanotoxicology 2013, 7(8):1386-1398.
81. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005, 6:2-8. ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group.
82. Ostrowski A., Nordmeyer D., Boreham A., Brodwolf R., Mundhenk L., Fluhr J.W., Lademann J., Graf C., Rühl E., Alexiev U., Gruber A.D. Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles. Nanomedicine 2014, 10(7):1571-1581.
83. Papakostas D., Rancan F., Sterry W., Blume-Peytavi U., Vogt A. Nanoparticles in dermatology. Arch. Dermatol. Res. 2011, 303(8):533-550.
84. Peira E., Turci F., Corazzari I., Chirio D., Battaglia L., Fubini B., Gallarate M. The influence of surface charge and photo-reactivity on skin-permeation enhancer property of nano-TiO2 in ex vivo pig skin model under indoor light. Int. J. Pharm. 2014, 467(1-2):90-99. 10.1016/j.ijpharm.2014.03.052.
85. Pflücker F., Wendel V., Hohenberg H., Gärtner E., Will T., Pfeiffer S., Wepf R., Gers-Barlag H. The human stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol. Appl. Skin Physiol. 2001, 14(Suppl. 1):92-97.
86. Pichardo-Geisinger R., Muñoz-Ali D., Arcury T.A., Blocker J.N., Grzywacz J.G., Mora D.C., Chen H., Schulz M.R., Feldman S.R., Quandt S.A. Dermatologist-diagnosed skin diseases among immigrant Latino poultry processors and other manual workers in North Carolina. USA Int. J. Dermatol. 2013, 52(11):1342-1348.
87. Pinheiro T., Pallon J., Alves L.C., Verissimo A., Filipe P., Silva J.N., Silva R. The influence of corneocyte structure on the interpretation of permeation profiles of nanoparticles across the skin. Nucl. Instr. Meth. Phys. Res. B. 2007, 260:119-123.
88. Poland C.A., Read S.A.K., Varet J., Carse G., Christensen F.M., Hankin S.M. Dermal absorption of nanomaterials; part of the "better control of nano" initiative 2012-2015. Danish Environ. Prot. Agency 2013, (ISBN No.978-87-93026-50-6).
89. Prow T.W., Monteiro-Riviere N.A., Inman A.O., Grice J.E., Chen X., Zhao X., Sanchez W.H., Gierden A., Kendall M.A., Zvyagin A.V., Erdmann D., Riviere J.E., Roberts M.S. Quantum dot penetration into viable human skin. Nanotoxicology 2012, 6(2):173-185.
90. Quandt S.A., Newman J.C., Pichardo-Geisinger R., Mora D.C., Chen H., Feldman S.R., Arcury T.A. Self-reported skin symptoms and skin-related quality of life among latino immigrant poultry processing and other manual workers. Am. J. Ind. Med. 2013, 10.1002/ajim.22291.
91. Ramos-e-Silva M., Jacques Cd. Epidermal barrier function and systemic diseases. Clin. Dermatol. 2012, 30(3):277-279.
92. Rancan F., Vogt A. Getting under the skin: what is the potential of the transfollicular route in drug delivery?. Ther. Deliv. 2014, 5(8):875-877.
93. Rancan F., Gao Q., Graf C., Troppens S., Hadam S., Vogt A. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size; surface functionalization and colloidal stability. ACS Nano 2012, 8:6829-6842.
94. Ravichandran S., Mortensen L.J., DeLuise L.A. Quantification of human skin barrier function and susceptibility to quantum dot skin penetration. Nanotoxicology 2011, 5(4):675-686.
95. Roberts M.S., Roberts M.J., Robertson T.A., Sanchez W., Thorling C., Zhou Y. In vitro and in vivo imaging of xenobiotic transport in human skin and in the rat liver. J. Biophotonics 2008, 1:478-493.
96. Rouse J.G., Yang J., Ryman-Rasmussen J.P., Barron A.R., Monteiro-Riviere N.A. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007, 7:155-160.
97. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci. 2006, 91:159-165.
98. Ryu H.J., Seo M.Y., Jung S.K., Maeng E.H., Lee S.Y., Jang D.H., Lee T.J., Jo K.Y., Kim Y.R., Cho K.B., Kim M.K., Lee B.J., Son S.W. Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats. Int. J. Nanomed. 2014, 9(Suppl. 2):137-144. 10.2147/IJN.S57930.
99. Sadrieh N., Wokovich A.M., Gopee N.V., Zheng J., Haines D., Parmiter D., Siitonen P.H., Cozart C.R., Patri A.K., McNeil S.E., Howard P.C., Doub W.H., Buhse L.F. Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles. Toxicol. Sci. 2010, 115(1):156-166.
100. Samberg M.E., Oldenburg S.J., Monteiro-Riviere N.A. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect. 2010, 118(3):407-413.
101. Scheuplein R.J. Mechanism of percutaneous absorption. I. Routes of penetration and the influence of solubility. J. Invest. Dermatol. 1965, 45:334-346.
102. Scheuplein R.J. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J. Invest. Dermatol. 1967, 48:79-88.
103. Schneider M., Stracke F., Hansen S., Schaefer U.F. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 2009, 4:197-206.
104. Schulz J., Hohenberg H., Pflücker F., Gartner E., Will T., Pfei Ver S., Wepf R., Wendel V., Gers-Barlag H., Wittern K.P. Distribution of sunscreens on skin. Adv. Drug Deliv. Rev. 2002, 54(S1):S157-S163.
105. Senzui M., Tamura T., Miura K., Ikarashi Y., Watanabe Y., Fuji M. Study on penetration of titanium dioxide (TiO2) nanoparticles into intact and damaged skin in vitro. J. Toxicol. Sci. 2010, 35:107-113.
106. Seto J.E., Polat B.E., Lopez R.F.V., Blankschtein D., Langer R. Effects of ultrasound and sodium lauryl sulphate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and split-thickness pig and human skin. J. Control. Release 2010, 145:26-32.
107. Sonavane G., Tomoda K., Sano A., Ohshima H., Terada H., Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf. B 2008, 65:1-10.
108. Staroňová K., Nielsen J.B., Roursgaard M., Knudsen L.E. Transport of SiO2 nanoparticles through human skin. Basic Clin. Pharmacol. Toxicol. 2012, 111(2):142-144.
109. Szikszai Z., Kertész Z., Bodnár E., Majora I., Borbíróc I., Kissa A.Z., Hunyadi J. Nuclear microprobe investigation of the penetration of ultrafine zinc oxide into intact and tape-stripped human skin. Nucl. Instr. Meth. Phys. Res., Sect. B 2010, 268(11-12):2160-2163.
110. Tan M.H., Commens C.A., Bumett L., Snitch P.J. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Aust. J. Dermatol. 1996, 37:185-187.
111. Tang L., Zhang C., Song G., Jin X., Xu Z. In vivo skin penetration and metabolic path of quantum dots. Sci. Chin. Life Sci. 2013, 56(2):181-188.
112. Tinkle S.S., Antonini J.M., Rich B.A., Roberts J.R., Salmen R., DePree K., Adkins E.J. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 2003, 111:1202-1208.
113. Upadhyay P. Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. Vaccine 2006, 24(27-28):5593-5598.
114. van der Merwe D., Tawde S., Pickrell J.A., Erickson L.E. Nanocrystalline titanium dioxide and magnesium oxide in vitro dermal absorption in human skin. Cutan. Ocul. Toxicol. 2009, 28(2):78-82.
115. Vermula P.K., Anderson R.R., Karp J.M. Nanoparticles reduce nickel allergy by capturing metal ions. Nat. Nanotechnol. 2011, 5:291-295.
116. Vogt A., Combadiere B., Hadam S., Stieler K.M., Lademann J., Schaefer H., Autran B., Sterry W., Blume-Peytavi U. 40nm, but not 750 or 1,500nm nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J. Invest. Dermatol. 2006, 126(6):1316-1322.
117. Vogt A., Rancan F., Ahlberg S., Nazemi B., Choe C.S., Darvin M.E., Hadam S., Blume-Peytavi U., Loza K., Diendorf J., Epple M., Graf C., Rühl E., Meinke M.C., Lademann J. Interaction of dermatologically relevant nanoparticles with skin cells and skin. Beilstein J. Nanotechnol. 2014, 2014(5):2363-2373. 10.3762/bjnano.5.245. eCollection.
118. Wang L., Qin G., Geng S., Dai Y., Wang J.Y. Preparation of zein conjugated quantum dots and their in vivo transdermal delivery capacity through nude mouse skin. J. Biomed. Nanotechnol. 2013, 9(3):367-376.
119. Watkinson A.C., Bunge A.L., Hadgraft J., Lane M.E. Nanoparticles do not penetrate human skin - a theoretical perspective. Pharm. Res. 2013, 30(8):1943-1946.
120. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H.W., Roszek B., Bisschops J., Gosens I., Van De Meent D., Dekkers S., De Jong W.H., Van Zijverden M., Sips A.J.A.M., Geertsma R.E. Nano-silver: a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3(2):109-138.
121. Wolff-Schreiner E. Ultrastructural cytochemistry of the epidermis. Int. J. Dermatol. 1977, 16:77-102.
122. Wu J., Liu W., Xue C., Zhou S., Lan F., Bi L., Xu H., Yang X., Zeng F.D. Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol. Lett. 2009, 191(1):1-8.
123. Wu X., Landfester K., Musyanovych A., Guy R.H. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol. Physiol. 2009, 23(3):117-123.
124. Xia X.R., Monteiro-Riviere N.A., Riviere J.E. Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol. Appl. Pharmacol. 2010, 242:29-37.
125. Zhang L.W., Monteiro-Riviere N.A. Assessment of quantum dot penetration into intact; tape stripped; abraded and flexed rat skin. Skin Pharmacol. Physiol. 2008, 21:166-180.
126. Zhang L.W., Yu W.W., Colvin V.L., Monteiro-Riviere N.A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 2008, 228:200-211.
127. Zhu Y., Choe C.S., Ahlberg S., Meinke M.C., Alexiev U., Lademann J., Darvin M.E. Penetration of silver nanoparticles into porcine skin ex vivo using fluorescence lifetime imaging microscopy, Raman microscopy, and surface-enhanced Raman scattering microscopy. J. Biomed. Opt. 2015, 20(5):051006. 10.1117/1.JBO.20.5.051006.
128. Zvyagin A.V., Zhao X., Gierden A., Sanchez W., Ross J.A., Roberts M.S. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J. Biomed. Opt. 2008, 13(6):064031. 10.1117/1.3041492.